Christine A. Collins

4.9k total citations · 2 hit papers
62 papers, 3.3k citations indexed

About

Christine A. Collins is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Christine A. Collins has authored 62 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 18 papers in Hepatology and 17 papers in Epidemiology. Recurrent topics in Christine A. Collins's work include Hepatitis C virus research (17 papers), HIV/AIDS drug development and treatment (15 papers) and Regulation of Appetite and Obesity (15 papers). Christine A. Collins is often cited by papers focused on Hepatitis C virus research (17 papers), HIV/AIDS drug development and treatment (15 papers) and Regulation of Appetite and Obesity (15 papers). Christine A. Collins collaborates with scholars based in United States, United Kingdom and Japan. Christine A. Collins's co-authors include Richard B. Vallee, Sharron X. Lin, Robert A. Obar, Howard S. Shpetner, James A. Hammarback, Eric M. Yoshida, Thomas Reisch, Andrew Campbell, Preethi Krishnan and Jill Beyer and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

Christine A. Collins

60 papers receiving 3.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis

2014 646 citations Christine A. Collins et al. profile →
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment

2017 271 citations Christine A. Collins et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christine A. Collins United States	29	1.6k	1.5k	1.1k	669	585	62	3.3k
David A. Rudnick United States	32	785 0.5×	755 0.5×	1.4k 1.3×	494 0.7×	127 0.2×	58	2.8k
Peter M. Grob United States	22	517 0.3×	666 0.5×	1.2k 1.1×	129 0.2×	776 1.3×	38	3.1k
Scott L. Harbeson United States	17	556 0.3×	428 0.3×	703 0.6×	249 0.4×	232 0.4×	28	1.7k
Wei Tang United States	29	272 0.2×	255 0.2×	1.5k 1.3×	80 0.1×	72 0.1×	88	2.8k
V. Joulin France	29	202 0.1×	358 0.2×	2.0k 1.8×	188 0.3×	35 0.1×	67	3.4k
Guido J.R. Zaman Netherlands	34	58 0.0×	188 0.1×	1.9k 1.7×	286 0.4×	228 0.4×	87	4.2k
Hyock Joo Kwon United States	21	76 0.0×	327 0.2×	1.7k 1.6×	539 0.8×	85 0.1×	26	3.3k
Brian Dymock Singapore	30	104 0.1×	118 0.1×	1.8k 1.6×	101 0.2×	144 0.2×	78	2.9k
Yuki Ohsaki Japan	29	188 0.1×	512 0.4×	1.4k 1.3×	757 1.1×	30 0.1×	53	2.6k
Joerg Kallen Switzerland	31	38 0.0×	212 0.1×	1.9k 1.7×	322 0.5×	55 0.1×	58	3.6k

Countries citing papers authored by Christine A. Collins

Since Specialization

Citations

This map shows the geographic impact of Christine A. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine A. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine A. Collins more than expected).

Fields of papers citing papers by Christine A. Collins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine A. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine A. Collins. The network helps show where Christine A. Collins may publish in the future.

Co-authorship network of co-authors of Christine A. Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Christine A. Collins. A scholar is included among the top collaborators of Christine A. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine A. Collins. Christine A. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tam, Edward, Rakesh Tripathi, Daniel E. Cohen, et al.. (2014). In Vitro and In Vivo Antiviral Activity and Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor ABT-450. Antimicrobial Agents and Chemotherapy. 59(2). 988–997. 102 indexed citations

King, Andrew, Jason A. Segreti, Andrew J. Souers, et al.. (2010). In vivo efficacy of acyl CoA: Diacylglycerol acyltransferase (DGAT) 1 inhibition in rodent models of postprandial hyperlipidemia. European Journal of Pharmacology. 637(1-3). 155–161. 28 indexed citations

Yang, Ruojing, Denise M. Wilcox, Deanna L. Haasch, et al.. (2007). Liver-specific Knockdown of JNK1 Up-regulates Proliferator-activated Receptor γ Coactivator 1β and Increases Plasma Triglyceride despite Reduced Glucose and Insulin Levels in Diet-induced Obese Mice. Journal of Biological Chemistry. 282(31). 22765–22774. 51 indexed citations

Zhao, Hongyu, Michael D. Serby, Ning Cao, et al.. (2007). Discovery of 1-(4-phenoxypiperidin-1-yl)-2-arylaminoethanone stearoyl-CoA desaturase 1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(12). 3388–3391. 26 indexed citations

Fry, Dennis G., Brian D. Dayton, Sevan Brodjian, et al.. (2006). Characterization of a neuronal cell line expressing native human melanin-concentrating hormone receptor 1 (MCHR1). The International Journal of Biochemistry & Cell Biology. 38(8). 1290–1299. 7 indexed citations

Wilcox, Denise M., Ruojing Yang, Sherry J. Morgan, et al.. (2006). Delivery of RNAi reagents in murine models of obesity and diabetes.. Europe PMC (PubMed Central). 8 indexed citations

Falls, Hugh D., Brian D. Dayton, Verlyn G. Schaefer, et al.. (2006). Characterization of ghrelin receptor activity in a rat pituitary cell line RC-4B/C. Journal of Molecular Endocrinology. 37(1). 51–62. 23 indexed citations

Xu, Haiyan, Denise Wilcox, Phong Nguyen, et al.. (2006). Hepatic knockdown of mitochondrial GPAT1 in ob/ob mice improves metabolic profile. Biochemical and Biophysical Research Communications. 349(1). 439–448. 57 indexed citations

Souers, Andrew J., Ju Gao, Dariusz Wódka, et al.. (2005). Synthesis and evaluation of urea-based indazoles as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity. Bioorganic & Medicinal Chemistry Letters. 15(11). 2752–2757. 35 indexed citations

10.

Zhao, Hongyu, Zhili Xin, Lissa T.J. Nelson, et al.. (2005). Structure–activity relationship studies on tetralin carboxamide growth hormone secretagogue receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(7). 1825–1828. 15 indexed citations

11.

Liu, Bo, Gang Liu, Zhili Xin, et al.. (2004). Novel isoxazole carboxamides as growth hormone secretagogue receptor (GHS-R) antagonists. Bioorganic & Medicinal Chemistry Letters. 14(20). 5223–5226. 21 indexed citations

12.

Souers, Andrew J., Dariusz Wódka, Ju Gao, et al.. (2004). Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 1. Bioorganic & Medicinal Chemistry Letters. 14(19). 4873–4877. 23 indexed citations

13.

McNally, Teresa, Terry M. Pederson, Stevan W. Djurić, et al.. (2004). Cloning and characterization of the glucagon receptor from cynomologous monkey. Peptides. 25(7). 1171–1178.

14.

Souers, Andrew J., Dariusz Wódka, Ju Gao, et al.. (2004). Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 3. Bioorganic & Medicinal Chemistry Letters. 14(19). 4883–4886. 15 indexed citations

15.

Collins, Christine A. & Philip R. Kym. (2003). Prospects for obesity treatment: MCH receptor antagonists.. PubMed. 4(4). 386–94. 25 indexed citations

16.

Collins, Christine A., et al.. (1995). Microtubule-independent Phospholipid Stimulation of Cytoplasmic Dynein ATPase Activity. Journal of Biological Chemistry. 270(9). 4492–4496. 9 indexed citations

17.

Oda, Hitoshi, Richard J. Stockert, Christine A. Collins, et al.. (1995). Interaction of the Microtubule Cytoskeleton with Endocytic Vesicles and Cytoplasmic Dynein in Cultured Rat Hepatocytes. Journal of Biological Chemistry. 270(25). 15242–15249. 66 indexed citations

18.

Collins, Christine A.. (1991). [21] Reversible assembly purification of taxol-treated microtubules. Methods in enzymology on CD-ROM/Methods in enzymology. 196. 246–253. 15 indexed citations

19.

Paschal, Bryce M., Stephen M. King, Anthony G. Moss, et al.. (1987). Isolated flagellar outer arm dynein translocates brain microtubules in vitro. Nature. 330(6149). 672–674. 96 indexed citations

20.

Seyfred, Mark A., Russell E. Kohnken, Christine A. Collins, & David G. McConnell. (1984). Rapid diglyceride phosphorylation in isolated bovine rod outer segments. Biochemical and Biophysical Research Communications. 123(1). 121–127. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact